Our results demonstrated that IL-27 stimulated synthesis of CRAMP/LL-37 in intestinal epithelial cells, suggesting that IL-27-LL-37 axis may be a valuable immunotherapy target for human CDI. The gene discussed is CAMP; the disease is clostridium difficile infection.